Co-Diagnostics (NASDAQ: CODX) reported Q1 EPS of ($0.24), $0.10 better than the analyst estimate of ($0.34). Revenue for the quarter came in at $50 thousand versus the consensus estimate of $400 thousand.

For earnings history and earnings-related data on Co-Diagnostics (CODX) click here.